Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T R Auton

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of Computer-Aided Molecular Design|December 3, 1998
Empirical scoring functions. II. The testing of an empirical scoring function for the prediction of ligand-receptor binding affinities and the use of Bayesian regression to improve the quality of the modelC W Murray, T R Auton, M D Eldridge
Human & Experimental Toxicology|May 1, 1993
Modelling dermal pharmacokinetics using in vitro data. Part I. Fluazifop-butyl in the ratT R Auton, J D Ramsey, B H Woollen
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|August 1, 1994
The predictive accuracy of in vitro measurements for the dermal absorption of a lipophilic penetrant (fluazifop-butyl) through rat and human skinJ D Ramsey, B H Woollen, T R Auton, et al.
Journal of Computer-Aided Molecular Design|December 31, 1997
Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexesM D Eldridge, C W Murray, T R Auton, et al.
Human & Experimental Toxicology|January 1, 1994
A physiologically based mathematical model of dermal absorption in manT R Auton, D R Westhead, B H Woollen, et al.
Human & Experimental Toxicology|July 1, 1992
Pharmacokinetics of fluazifop-butyl in human volunteers. II: Dermal dosingJ D Ramsey, B H Woollen, T R Auton, et al.
Pharmaceutical Research|October 1, 1994
Vehicle effects on in vitro percutaneous absorption through rat and human skinJ Hilton, B H Woollen, R C Scott, et al.
International Archives of Occupational and Environmental Health|January 1, 1992
Human inhalation pharmacokinetics of chlorodifluoromethane (HCFC22)B H Woollen, J R Marsh, J D Mahler, et al.
International Archives of Occupational and Environmental Health|January 1, 1990
Human inhalation pharmacokinetics of 1,1,2-trichloro-1,2,2-trifluoroethane (FC113)B H Woollen, E A Guest, W Howe, et al.
Toxicology and Applied Pharmacology|July 1, 1995
Inhibition of 4-hydroxyphenylpyruvate dioxygenase by 2-(2-nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione and 2-(2-chloro-4-methanesulfonylbenzoyl)-cyclohexane-1,3-dioneM K Ellis, A C Whitfield, L A Gowans, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Computer-Aided Molecular Design|December 3, 1998
Empirical scoring functions. II. The testing of an empirical scoring function for the prediction of ligand-receptor binding affinities and the use of Bayesian regression to improve the quality of the modelC W Murray, T R Auton, M D Eldridge
Human & Experimental Toxicology|May 1, 1993
Modelling dermal pharmacokinetics using in vitro data. Part I. Fluazifop-butyl in the ratT R Auton, J D Ramsey, B H Woollen
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|August 1, 1994
The predictive accuracy of in vitro measurements for the dermal absorption of a lipophilic penetrant (fluazifop-butyl) through rat and human skinJ D Ramsey, B H Woollen, T R Auton, et al.
Journal of Computer-Aided Molecular Design|December 31, 1997
Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexesM D Eldridge, C W Murray, T R Auton, et al.
Human & Experimental Toxicology|January 1, 1994
A physiologically based mathematical model of dermal absorption in manT R Auton, D R Westhead, B H Woollen, et al.
Human & Experimental Toxicology|July 1, 1992
Pharmacokinetics of fluazifop-butyl in human volunteers. II: Dermal dosingJ D Ramsey, B H Woollen, T R Auton, et al.
Pharmaceutical Research|October 1, 1994
Vehicle effects on in vitro percutaneous absorption through rat and human skinJ Hilton, B H Woollen, R C Scott, et al.
International Archives of Occupational and Environmental Health|January 1, 1992
Human inhalation pharmacokinetics of chlorodifluoromethane (HCFC22)B H Woollen, J R Marsh, J D Mahler, et al.
International Archives of Occupational and Environmental Health|January 1, 1990
Human inhalation pharmacokinetics of 1,1,2-trichloro-1,2,2-trifluoroethane (FC113)B H Woollen, E A Guest, W Howe, et al.
Toxicology and Applied Pharmacology|July 1, 1995
Inhibition of 4-hydroxyphenylpyruvate dioxygenase by 2-(2-nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione and 2-(2-chloro-4-methanesulfonylbenzoyl)-cyclohexane-1,3-dioneM K Ellis, A C Whitfield, L A Gowans, et al.
Pageof 3